Health Care & Life Sciences » Biotechnology | OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 38.5 M
Public Float
 28.42 M
OncoMed Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $0.28
Market Cap
 $103.96 M
Shares Outstanding
 38.5 M
Public Float
 25.73 M

Profile

Address
800 Chesapeake Drive
Redwood City California 94063
United States
Employees -
Website http://www.oncomed.com
Updated 09/14/2018
OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.

Financials

View All
Created with Highcharts 5.0.14OncoMed Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.26 07126 07150 01050 01085 40785 407103 102103 10239 06239 06220132014201520162017025k50k75k100k125k
Created with Highcharts 5.0.14OncoMed Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.37 77937 77939 55939 55925 89925 89925 15325 15338 15438 15420132014201520162017010k20k30k40k50k

Perry A. Karsen
Executive Chairman
John A. Lewicki
President, Chief Executive Officer & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.